pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,159 catalysts · 5,159 phase readout · 2,290 8k filing · 315 pdufa · 257 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 18 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: filing×type: recall×type: phase readout×clear all
type
  • phase readout5,159
  • 8k filing2,290
  • pdufa315
  • earnings257
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›RECRUITINGphase readoutNCT07322302: RESTORE: Comparing Two Approaches to Repeat TT Surgery Performed by Integrated Eye Care Workers (IECWs)

Sponsor: University of North Carolina, Chapel Hill. Phase: NA. Conditions: Trachoma, Eye Diseases, Trichiasis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07079631: A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer

Sponsor: BioNTech SE. Phase: PHASE1. Conditions: Metastatic Colorectal Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06420531: Milk And Growth In Children (MAGIC) Born Very Preterm: A Randomized Trial

Sponsor: University of Alabama at Birmingham. Phase: NA. Conditions: Prematurity

full page →ctgov ↗
›RECRUITINGphase readoutNCT04946253: SKIP for PA Study: Team and Leadership Level Implementation Support for Collaborative Care

Sponsor: University of Pittsburgh. Phase: NA. Conditions: Child Behavior Problem, Attention Deficit and Disruptive Behavior Disorders

full page →ctgov ↗
›TERMINATEDphase readoutNCT05175053: Early RRT in AKI After Cardiac Surgery

Sponsor: Seoul National University Hospital. Phase: NA. Conditions: Acute Kidney Injury

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07512245: Assessment of Two Soft Tissue Augmentation Using Acellular Dermis Around Dental Implants

Sponsor: University of Alabama at Birmingham. Phase: NA. Conditions: Acellular Dermal Matrix, Alveolar Mucosa

full page →ctgov ↗
›COMPLETEDphase readoutNCT02583672: Role of Oxidative Stress and Inflammation in Type 1 Gaucher Disease (GD1)

Sponsor: University of Minnesota. Phase: PHASE2. Conditions: Gaucher Disease Type 1

full page →ctgov ↗
›COMPLETEDphase readoutNCT04804072: INTEGRA: A Vanguard Study of Health Service Delivery in a Mobile Health Delivery Unit

Sponsor: HIV Prevention Trials Network. Phase: NA. Conditions: HIV Infections, Drug Use, Opioid Use, Opioid-use Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT01617395: Relating Genetic and Environmental Risk Scores to Multiple Sclerosis Susceptibility

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS). Phase: . Conditions: Multiple Sclerosis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04950439: Pyrophosphate and Arterial Calcification in Chronic Kidney Disease

Sponsor: Centre Hospitalier Universitaire de Nice. Phase: NA. Conditions: Chronic Kidney Diseases

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07327177: BFR Rope Training in Male Volleyball Players

Sponsor: Karabuk University. Phase: NA. Conditions: Volleyball, Performance, Power

full page →ctgov ↗
›COMPLETEDphase readoutNCT07050875: Clinical Investigation to Validate the Safety and Performance of the ABLE Exoskeleton Device for Individuals With Acquired Brain Injury in a Clinical Setting

Sponsor: ABLE Human Motion S.L.. Phase: NA. Conditions: Acquired Brain Injury (Including Stroke)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07346157: Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease

Sponsor: Sabine Mueller, MD, PhD. Phase: PHASE1. Conditions: Medulloblastoma, Medulloblastoma, Childhood, Medulloblastoma Recurrent

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05134857: The Zonisamide and Reinforcement for Reducing Alcohol Use (ZARRA) Study

Sponsor: Washington State University. Phase: PHASE2. Conditions: Alcohol Use Disorder (AUD)

full page →ctgov ↗
›RECRUITINGphase readoutNCT03972657: A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

Sponsor: Regeneron Pharmaceuticals. Phase: PHASE1. Conditions: Metastatic Castration-Resistant Prostate Cancer (mCRPC), Clear Cell Renal Cell Carcinoma (ccRCC)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06434012: Barts Endocarditis Research Registry

Sponsor: Queen Mary University of London. Phase: . Conditions: Infective Endocarditis, Endocarditis, Endocarditis, Bacterial

full page →ctgov ↗
›RECRUITINGphase readoutNCT07020312: Brain-Computer Interface Visualization Training to Optimize Muscle Activation Following Orthopaedic Surgery

Sponsor: Rush University Medical Center. Phase: PHASE2. Conditions: Anterior Cruciate Ligament Reconstruction, Total Hip Arthroplasty (THA), Total Knee Arthroplasty, Hip Arthroscopy

full page →ctgov ↗
›RECRUITINGphase readoutNCT07325630: Perioprative Study of IBI363 in Patients With MHC-II-Negative Locally Advanced Gastric Cancer

Sponsor: Zhejiang Cancer Hospital. Phase: PHASE2. Conditions: IBI363 + Chemotherapy

full page →ctgov ↗
›RECRUITINGphase readoutNCT00001230: Host Response to Infection and Treatment in Filarial Diseases

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: . Conditions: Filariasis, Helminthiasis, Parasitic Infection, Mansonelliasis, Onchocerciasis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06883630: A Phase Ib Study of RC148 as Monotherapy or Combination for Locally Advanced or Metastatic NSCLC

Sponsor: RemeGen Co., Ltd.. Phase: PHASE1. Conditions: Non-Small Cell Lung Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT05865028: A Proof of Concept Trial Investigating Safety and Efficacy of APG-157 in Oral Dysplasia

Sponsor: Elizabeth J Franzmann. Phase: PHASE2. Conditions: Oropharyngeal Dysplasia, Oral Cavity Dysplasia, Oral Carcinoma in Situ

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06439628: ARISE-A Chinese Real-world Study of Rimegepant for the Acute Treatment of Migraine

Sponsor: Chinese PLA General Hospital. Phase: . Conditions: Migraine

full page →ctgov ↗
›COMPLETEDphase readoutNCT06282328: HIV HOspital TEsting: Bringing the Hidden to Light in the Hospital Setting

Sponsor: Castagna Antonella. Phase: . Conditions: Hiv, HIV Infections, AIDS

full page →ctgov ↗
›RECRUITINGphase readoutNCT07398365: Medical Phenotyping of NHS General Adult Psychiatry (GAP) Inpatients

Sponsor: University of Edinburgh. Phase: . Conditions: Bipolar Affective Disorder, Schizophrenia Disorders, Depression Disorders, Personality Disorders

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07321067: Use of Immune Checkpoint Inhibitors in Patients With Advanced Hepatocellular Carcinoma : Efficacy and Outcomes

Sponsor: Ahmed Karam Helmy. Phase: . Conditions: Advanced Hepatocellular Carcinoma (HCC)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT02868268: Neuroblastoma Precision Trial

Sponsor: New Approaches to Neuroblastoma Therapy Consortium. Phase: . Conditions: Neuroblastoma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06766968: Prolonged Compression Following Foam Sclerotherapy

Sponsor: Pirogov Russian National Research Medical University. Phase: NA. Conditions: Chronic Venous Disorder, Varicose Veins Leg

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07562568: SHR2554/AZA + Overlapped TBF for High-risk/Relapsed Leukemia/MDS

Sponsor: The First Affiliated Hospital of Soochow University. Phase: PHASE2. Conditions: Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, MDS, Transplantation, Stem Cell, Conditioning Therapy, SHR2554, Azacytidine

full page →ctgov ↗
›WITHDRAWNphase readoutNCT06720740: The RELIEF™ Ureteral Stent Randomized Controlled Trial

Sponsor: University of California, San Diego. Phase: NA. Conditions: Kidney Stone

full page →ctgov ↗
›RECRUITINGphase readoutNCT05919940: Improved Muscle Metabolism by Combination of Muscle Activation and Protein Substitution ( IMEMPRO )

Sponsor: Technical University of Munich. Phase: NA. Conditions: ICU Acquired Weakness, Muscle Atrophy, Energy Malnutrition Protein, Quality of Life, Morphological and Microscopic Findings, Metabolic Disturbance

full page →ctgov ↗
›RECRUITINGphase readoutNCT07166289: Ultrasound Neuromodulation of Circuits and Negative Valence Systems in Treatment-Resistant Depression

Sponsor: Laureate Institute for Brain Research, Inc.. Phase: NA. Conditions: Treatment-Resistant Depression

full page →ctgov ↗
›RECRUITINGphase readoutNCT07343440: Trial on the Impact of Indirect Calorimetry-Guided Nutritional Support on Patient-Centered Outcomes in Critically Ill Patients - The OPTICal Study

Sponsor: HEIDEGGER CP. Phase: NA. Conditions: Critical Illness, ICU

full page →ctgov ↗
›COMPLETEDphase readoutNCT07024589: First-in-Human Trial of Oral AN2-502998

Sponsor: AN2 Therapeutics, Inc. Phase: PHASE1. Conditions: Healthy Volunteers

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05047250: A Study of Atezolizumab in High PD-L1 Expression, Chemotherapy-Naïve Patients With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer

Sponsor: Hoffmann-La Roche. Phase: PHASE3. Conditions: Non-Small Cell Lung Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07687550: Alterations in Spiking Following Muscle Fatigue in Volleyball Players

Sponsor: National Yang Ming Chiao Tung University. Phase: . Conditions: Fatigue

full page →ctgov ↗
›COMPLETEDphase readoutNCT05204550: Intranasal Heparin Treatment to Reduce Transmission Among Household Contacts of COVID 19 Positive Adults and Children

Sponsor: Murdoch Childrens Research Institute. Phase: PHASE2. Conditions: COVID-19

full page →ctgov ↗
›COMPLETEDphase readoutNCT07517991: Chlorhexidine and Zinc in Non-Surgical Periodontal Therapy

Sponsor: Ataturk University. Phase: NA. Conditions: Periodontitis, Periodontitis Stage I, Periodontitis Stage II

full page →ctgov ↗
›COMPLETEDphase readoutNCT03958591: Impact of Short-term Intensive De-escalation Therapy on Long-term Regimen Simplification

Sponsor: Yanbing Li. Phase: PHASE4. Conditions: Diabetes type2

full page →ctgov ↗
›RECRUITINGphase readoutNCT06529718: Testing Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer Patients

Sponsor: UNICANCER. Phase: PHASE2. Conditions: Biliary Tract Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT05051618: Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis

Sponsor: University of Illinois at Chicago. Phase: NA. Conditions: Multiple Sclerosis, Major Depressive Disorder

full page →ctgov ↗
›TERMINATEDphase readoutNCT06391918: Phase 1 Study of GEN2 in Patients With Advanced Solid Tumors

Sponsor: GenVivo, Inc.. Phase: PHASE1. Conditions: Solid Tumor, Adult

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07467720: Study to Evaluate the Clinical Utility of Radiation Exposure Reduction: Multi-site Rampart Guardian Peripheral Trial

Sponsor: Baylor Research Institute. Phase: NA. Conditions: Radiation Protection

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07378124: LLL vs. SDL for LBBP: A Non-inferiority RCT

Sponsor: Ningbo No.2 Hospital. Phase: NA. Conditions: Bradycardia, Conduction Block, Atrioventricular

full page →ctgov ↗
›RECRUITINGphase readoutNCT07415382: Frailty, Dual-Task Performance, and Activities of Daily Living in Older Adults

Sponsor: KTO Karatay University. Phase: . Conditions: Older Adults (60 - 85 Years Old)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06147024: Utilizing 3D Printed Personalized Aortic Lesion Models in Preoperative Assessment

Sponsor: Fu Jen Catholic University. Phase: NA. Conditions: Aortic Aneurysm

full page →ctgov ↗
›COMPLETEDphase readoutNCT06965959: Effects of Exergaming and Autogenic Relaxation on Psychological Well-Being in Nursing Home Residents

Sponsor: Cumhuriyet University. Phase: NA. Conditions: Psychological Well-being, Nursing Homes Residents, Aging, Exergaming, Mind-Body Therapies, Quality of Life, Health Promotion

full page →ctgov ↗
›RECRUITINGphase readoutNCT06915116: Acupuncture for People Experiencing Period Loss Due to Chemotherapy

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: Cancer, Period Problem

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT02041416: Technology to Assess Vulnerable Older Adults With Cancer and Their Caregivers

Sponsor: City of Hope Medical Center. Phase: . Conditions: Cancer, Solid Tumor, Hematologic Malignancy

full page →ctgov ↗
›RECRUITINGphase readoutNCT06282406: Pupil-Indexed Noninvasive Neuromodulation

Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Paresis

full page →ctgov ↗
›RECRUITINGphase readoutNCT04356287: Treatment With Human Umbilical Cord-derived Mesenchymal Stromal Cells in Systemic Sclerosis

Sponsor: Marie Hudson, MD. Phase: PHASE1. Conditions: Sclerosis, Systemic, Mesenchymal Stem Cells

full page →ctgov ↗
← prev
page 88 of 104
next →